Press Release
“Biology in Pico-Liter Droplets” is Focus of Presentation at LabAutomation 2009
LEXINGTON, MASSACHUSETTS, U.S.A., January 12, 2009 – Darren R. Link, Ph.D., of RainDance Technologies, Inc., will present “Biology in Pico-Liter Droplets,” a discussion of the commercialization of the use of picoliter droplets in microfluidic channels for applications in the life sciences, at the LabAutomation2009 conference on Wednesday, January 28, 2009, in Palm Springs, Calif.
RainDance Technologies is a provider of innovative microdroplet-based solutions which enable and benefit biological applications utilized in human health and disease research.
“In typical applications, cells, nucleic acids, enzymes, or other reagents are encapsulated in aqueous phase droplets dispersed in a fluorinated carrier oil. These droplets range from sub-picoliter to tens of nanoliters in volume, and are manipulated on an individual basis to perform bioassays. Manipulations such as adding reagents or sorting droplets based on their optical properties are achieved solely through the application of external electric fields. Since electric fields can be turned on or off at very high speeds, sorting rates exceeding several thousand per second are readily achieved. We will introduce the techniques used to generate and manipulate droplets and show several of the biological applications that are enabled by this technology,” said Dr. Link.
Dr. Link is Co-Founder and Vice President, Research and Development, RainDance Technologies (www.RainDancetech.com). He holds a B.S. degree in physics from Montana State University and a Ph.D. in physics from the University of Colorado. Before joining RainDance, he spent two years at Harvard University as a postdoctoral scientist studying soft materials physics in the department of physics and division of engineering and applied sciences. Dr. Link spent two years at Tokyo Institute of Technology as a postdoctoral scientist studying liquid crystalline materials. He has received grant funding from the U.S. Defense Advanced Research Projects Agency and participated in the National Science Foundation’s U.S.-Japan exchange program for young scientists in Nanotechnology. Dr. Link has co-authored more than 45 peer-reviewed articles and 10 patent applications. He also serves on the Industrial Advisory Board of the Vanderbilt Institute for Integrative Biosystems Research and Education.
Dr. Link will present “Biology in Pico-Liter Droplets” as part of the Micro- and Nanotechnologies conference track LabAutomation2009, Wednesday, January 28, 2009, from 9:30 AM to 10:00 AM in the Pasadena room of the Wyndham Hotel in Palm Springs, Calif.
LabAutomation2009 (www.labautomation.org/LA09), the world's leading conference and exhibition on emerging laboratory technologies, runs January 24-28, 2009.
About RainDance Technologies, Inc.
RainDance's proprietary technology platform delivers exquisite sensitivity and data quality that inspires scientists, researchers and clinicians to rethink the way they design experiments, approach discovery, or conduct clinical diagnostics. The core RainStorm™ technology empowers customers to conduct de novo science in an ultra-high throughput, simple, flexible, and low-cost manner. RainDance's commercial products include instruments and high-value consumables and reagents for sequence enrichment for next-generation sequencing, ultra-deep sequencing, and methylation analysis. RainDance sells directly in the U.S. and in Europe, and is building distribution networks in Europe and Asia-Pacific. RainDance Technologies has approximately 70 employees worldwide. For more information, please visit www.raindancetech.com.
RainStorm is a trademark of RainDance Technologies, Inc.
For corporate questions contact:
Chris McNary
RainDance Technologies
44 Hartwell Avenue
Lexington, MA 02421
Phone — 781-861-6300
mcnaryc@raindancetech.com
For technical questions contact:
James Brayer
RainDance Technologies
44 Hartwell Avenue
Lexington, MA 02421
Phone — 781-861-6300
info@raindancetech.com
For press inquiries:
Colin Sanford
Phone — 203-340-2441
colin@bioscribe.com
